J&J Bolsters Its Prospects in Brain Health With $14B Buyout of Intra-Cellular Therapies

Johnson & Johnson’s agreement to acquire Intra-Cellular Therapies brings Caplyta, which is projected to become a blockbuster seller across several neurological indications. In other M&A news, GSK and Eli Lilly each struck deals to fill their cancer drug pipelines. The post J&J Bolsters Its Prospects in Brain Health With $14B Buyout of Intra-Cellular Therapies appeared…

Read More

Journalists Talk Shooting’s Toll on Children and State Handling of Opioid Settlement Funds

KFF Health News Midwest correspondent Bram Sable-Smith discussed the enduring trauma experienced by children who survived the Super Bowl parade shooting earlier this year on KMOX’s “Total Information AM” on Aug. 22. Click here to hear Sable-Smith on “Total Information AM” Read Sable-Smith and Peggy Lowe’s “Kids Who Survived Super Bowl Shooting Are Scared, Suffering…

Read More

Roon – the Demo and Interview

I was a little surprised that in the days of limitless content, AI, and all types of medical information being online a company could raise $15m to create a platform where actual doctors could answer specific questions that patients might have. Vikram Bhaskaran, the CEO is ex Pinterest and knows the consumer world well. Rohan…

Read More

Adrian Owen & Faraz Shafaghi, Creyos

I spoke with neuroscientist Adrian Owen, co-founder and Chief Scientific Officer & Faraz Shafaghi, Chief Product Officer, at neurological testing company Creyos (which rhymes with “chaos”). Their cognitive assessment platform gives a baseline of neurological function and is essentially getting objective data at a point of care. This can now be done as part of…

Read More